Nick Muscato - Apr 21, 2022 Form 3 Insider Report for AMEDISYS INC (AMED)

Role: Chief Strategy Officer
Signature: Jennifer Guckert Griffin, pursuant to a power of attorney
Stock symbol: AMED
Transactions as of: Apr 21, 2022
Transactions value $: $0
Form type: 3
Date filed: 5/2/2022, 04:51 PM
Next filing: Jul 27, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	AMED	Common Stock						3.4K	Apr 21, 2022	Direct	F1
holding	AMED	Common Stock						213	Apr 21, 2022	By 401(k) Plan	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	AMED	Stock Option (Right to Buy)							Apr 21, 2022	Common Stock	272	$95.76	Direct	F3
holding	AMED	Stock Option (Right to Buy)							Apr 21, 2022	Common Stock	320	$132.41	Direct	F4
holding	AMED	Stock Option (Right to Buy)							Apr 21, 2022	Common Stock	563	$214.74	Direct	F5
holding	AMED	Stock Option (Right to Buy)							Apr 21, 2022	Common Stock	708	$264.00	Direct	F6
holding	AMED	Stock Option (Right to Buy)							Apr 21, 2022	Common Stock	2.04K	$143.25	Direct	F7
holding	AMED	Restricted Stock Unit (Performance-Based Vesting)							Apr 21, 2022	Common Stock	1.75K		Direct	F8

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents restricted stock units ("RSUs") that vest based on the passage of time. 1,824 of the RSUs vest on July 25, 2022, 386 of the RSUs vest on July 25, 2023, 247 of the RSUs vest on July 25, 2024, 72 of the RSUs vest on July 25, 2025, 218 of the RSUs vest on February 20, 2023, 218 of the RSUs vest on February 20, 2024, 218 of the RSUs vest on February 20, 2025 and 219 of the RSUs vest on February 20, 2026, assuming the Reporting Person remains continuously employed by the Issuer on each such vesting date, subject to certain pro-rated vesting provisions as provided in the award agreement for the RSUs.
F2	The information in this report is based on a plan statement dated as of March 31, 2022.
F3	The Stock Options are subject to time-based vesting conditions and will vest on July 25, 2022, provided that the Reporting Person remains continuously employed by the Issuer on such date, subject to pro-rated vesting provisions as provided in the award agreement for the Stock Options.
F4	The Stock Options are subject to time-based vesting conditions. 107 Stock Options vested on July 25, 2021, 107 Stock Options will vest on July 25, 2022 and 106 Stock Options will vest on July 25, 2023, provided that the Reporting Person remains continuously employed by the Issuer on each such date, subject to pro-rated vesting provisions as provided in the award agreement for the Stock Options.
F5	The Stock Options are subject to time-based vesting conditions. 140 Stock Options vested on July 25, 2021, and 141 Stock Options will vest on each of July 25, 2022, July 25, 2023 and July 25, 2024, provided that the Reporting Person remains continuously employed by the Issuer on each such date, subject to pro-rated vesting provisions as provided in the award agreement for the Stock Options.
F6	The Stock Options are subject to time-based vesting conditions. 177 Stock Options vest on each of July 25, 2022, July 25, 2023, July 25, 2024 and July 25, 2025, provided that the Reporting Person remains continuously employed by the Issuer on each such date, subject to pro-rated vesting provisions as provided in the award agreement for the Stock Options.
F7	The Stock Options are subject to time-based vesting conditions. 510 Stock Options vest on each of July 25, 2023, July 25, 2024, July 25, 2025 and July 25, 2026, provided that the Reporting Person remains continuously employed by the Issuer on each such date, subject to pro-rated vesting provisions as provided in the award agreement for the Stock Options.
F8	The performance-based RSUs will vest based on certification of achievement of an identified performance measure for 2022, with additional time-based vesting in equal 25% installments on each of the certification date and February 20, 2024, 2025 and 2026, assuming the Reporting Person remains continuously employed on the vesting date. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved.

Remarks:

Exhibit 24.1 - Power of Attorney